Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Recent & Breaking News (NYSE:GSK)

Pharma Catches Another Case Of M&A Fever

Benzinga.com  February 1, 2019

TD Ameritrade IMX Continued Its Dip In December, Falling To A More Than Two-Year Low

Benzinga.com  January 8, 2019

FinancialBuzz.com: 'Federal Reserve Raises Interest Rates' Video Recap Week Ending December 21st, 2018

PR Newswire December 21, 2018

GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses

Benzinga.com  December 19, 2018

Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company

Business Wire December 19, 2018

Financialbuzz.com: 'Trade War Cease Fire' Video Recap Week Ending December 7th, 2018

PR Newswire December 7, 2018

Explosion of Latest Clinical Studies and Results Reinvigorating Immunotherapy Market

PR Newswire December 4, 2018

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Tesaro, Inc. (TSRO) on Behalf of Stockholders and Encourages TSRO Investors to Contact the Firm

GlobeNewswire December 3, 2018

Mid-Afternoon Market Update: Tesaro Climbs On Acquisition News; Tonix Pharmaceuticals Shares Slide

Benzinga.com  December 3, 2018

46 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  December 3, 2018

Mid-Day Market Update: Hexindai Falls After Q2 Results; Global Blood Therapeutics Shares Surge

Benzinga.com  December 3, 2018

Mid-Morning Market Update: Markets Open Higher; Nexstar to buy Tribune Media for $46.50/Share

Benzinga.com  December 3, 2018

GlaxoSmithKline Strikes $5B M&A Deal With Tesaro In Quest To Boost Oncology Franchise

Benzinga.com  December 3, 2018

Tesaro (TSRO) Alert: Johnson Fistel Investigates Proposed Sale of Tesaro, Inc. to GlaxoSmithKline plc; Are Shareholders Getting a Fair Deal?

PR Newswire December 3, 2018

GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company

GlobeNewswire December 3, 2018

Once-daily Trelegy Ellipta gains expanded COPD indication in Europe

Business Wire November 9, 2018

Report: Developing Opportunities within Avon Products, Sanofi, Arch Coal, GlaxoSmithKline plc, Chimera Investment, and PTC — Future Expectations, Projections Moving into 2018

GlobeNewswire November 6, 2018

NeuroMetrix Reports Q3 2018 Financial Results

GlobeNewswire October 17, 2018

New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire September 26, 2018

NeuroMetrix Reports Q2 2018 Financial Results

GlobeNewswire July 19, 2018